Bio-Techne Corporation reported its fiscal third-quarter 2026 results in early May, with net sales of US$311.42 million, a 2% year-over-year decline, while net income rose to US$51.05 million and ...
网页链接Bio-Techne Corporation reported its fiscal third-quarter 2026 results in early May, with net sales of US$311.42 million, a 2% year-over-year decline, while net income rose to US$51.05 million and ...
网页链接免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。